Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope
Crossref DOI link: https://doi.org/10.1007/s00204-016-1876-7
Published Online: 2016-10-20
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kizhedath, Arathi http://orcid.org/0000-0002-6939-6416
Wilkinson, Simon
Glassey, Jarka
Funding for this research was provided by:
EU-Horizon 2020 Marie Skłodowska-Curie actions (MSCA) ITN project BIORAPID (643056)
License valid from 2016-10-20